GlassScriptPhysician profile
John J O Connell
NPI 1720028186
$3,124.89
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,532 · 2020: $504 · 2021: $210 · 2022: $431 · 2023: $225 · 2024: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $517.00 | 2019-2020 | |
| Organogenesis INC. | $494.64 | 2021-2024 | Puraply |
| Abbvie INC. | $182.10 | 2021-2024 | |
| Lilly USA, LLC | $173.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $159.19 | 2019 | |
| Mylan Specialty L.P. | $128.84 | 2019 | |
| Pfizer INC. | $120.42 | 2019 | |
| Medtronic Vascular, INC. | $109.79 | 2019 | |
| Amarin Pharma, INC. | $107.75 | 2019-2020 | |
| Allergan, INC. | $104.98 | 2019-2020 | |
| Smith+Nephew, INC. | $102.34 | 2021-2024 | Collagenase Santyl, Regranex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.31 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $78.97 | 2019-2020 | |
| Amgen INC. | $76.69 | 2019-2020 | |
| Kci USA, INC. | $76.48 | 2021-2023 | V.A.C. Dermatac |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $70.93 | 2019 | |
| Paratek Pharmaceuticals, INC. | $57.70 | 2022-2023 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.22 | 2019 | |
| Eisai INC. | $50.55 | 2019-2020 | |
| Astellas Pharma US INC | $42.36 | 2019 | |
| Kerecis Limited | $36.97 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Shire North American Group INC | $30.57 | 2019 | |
| Hartmann USA, INC. | $28.25 | 2022 | |
| Novo Nordisk INC | $27.98 | 2019 | |
| Ets Wound Care LLC | $27.31 | 2024 | Mirragen Advanced Wound Matrix |
| Tanabe Pharma America, INC. | $22.00 | 2019 | |
| Aquestive Therapeutics, INC. | $21.48 | 2021 | |
| Lundbeck LLC | $20.72 | 2020 | |
| Next Science LLC | $20.01 | 2023 | Surgx, Xperience, Blastx |
| Genentech USA, INC. | $18.28 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.52 | 2019 | |
| Convatec INC. | $15.79 | 2023 | |
| Currax Pharmaceuticals LLC | $14.24 | 2020 | |
| Tactile Systems Technology INC | $14.16 | 2022 | |
| Greenwich Biosciences, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John O Connell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.